Clinical Trials Directory

Trials / Sponsors / Vifor (International) Inc.

Vifor (International) Inc.

Industry · 10 registered clinical trials.

StatusTrialPhaseStarted
WithdrawnCross-sectional Study to Assess Prevalence and Burden of CKD-associated Pruritus in Hemodialysis Patients
Chronic Kidney Disease-associated Pruritus
—2023-06-10
CompletedCross-sectional Study to Assess Prevalence and Burden of CKD-associated Pruritus in Haemodialysis Patients
Chronic Kidney Disease-associated Pruritus
—2023-02-02
CompletedRAYALDEE Non Interventional Study (NIS) on Effectiveness in ND-CKD SHPT Patients
Chronic Kidney Disease
—2022-10-05
CompletedStudy to Assess Efficacy and Safety of VIT-2763 (Vamifeport) in Subjects With Sickle Cell Disease
Sickle Cell Disease
Phase 22021-11-18
CompletedBioavailability Study Comparing 2 Vamifeport Oral Formulations in Fasted Versus Fed State in Healthy Subjects
Healthy
Phase 12021-10-14
WithdrawnEfficacy and Safety Study of Multiple Doses of VIT-2763 in Adults With Transfusion-dependent Beta-thalassemia
Beta-Thalassemia
Phase 22021-09-20
CompletedCardiovascular and Renal Treatment in Heart Failure Patients With Hyperkalaemia or at High Risk of Hyperkalaem
Heart Failure, Hyperkalemia
—2021-04-19
CompletedSafety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Preliminary Efficacy of VIT-2763 in β-t
Beta-Thalassemia, Non-transfusion-dependent Thalassemia
Phase 22020-06-11
CompletedTo Assess the Impact of Ferric Carboxymaltose Compared With Iron Sucrose in Chinese Subjects on Correcting Iro
Iron Deficiency Anemia
Phase 32017-07-03
CompletedStudy to Compare Ferric Carboxymaltose With Placebo in Patients With Acute Heart Failure and Iron Deficiency
Iron Deficiency, Heart Failure
Phase 42017-04-03